Novartis Pharmaceuticals Paralegal Salary | Comparably
Novartis Pharmaceuticals Claimed Company
Our mission is to discover new ways to improve and extend people's lives. read more
EMPLOYEE
PARTICIPANTS
199
TOTAL
RATINGS
1588
HR or Marketing? Claim Your Free Employer Account

Novartis Pharmaceuticals Paralegal Salary

The average Novartis Pharmaceuticals Paralegal earns an estimated $68,031 annually. Novartis Pharmaceuticals' Paralegal compensation is $4,185 more than the US average for a Paralegal.

The Legal Department at Novartis Pharmaceuticals earns $34,085 more on average than the Product Department.

Last updated 2 years ago.

$29k
$39k
$49k
$58k
$98k
$145k
$174k
$68,031
Average Compensation
$68,031
avg. base

Paralegal Salaries at Novartis Pharmaceuticals

Paralegals earn $126,423 less than Corporate Counsels.

General Counsel
$212k*
Corporate Counsel
$194k*
* estimated salary

Compensation at Novartis Pharmaceuticals by Department

The Legal Department averages $34,085 more than the Product Department, and $11,995 less than the Enterprise Risk Department

Enterprise Risk
$182,767 Avg. total comp.
+$12k
Legal
$170,772 Avg. total comp.
Product
$136,687 Avg. total comp.
-$34k

Paralegal Compensation by Gender (All Companies)

The average female Paralegal at companies similar size to Novartis Pharmaceuticals reported making $79,310, while the average male Paralegal at similar sized companies reported making $73,750.

Paralegal Compensation by Ethnicity (All Companies)

The average African American/Black Paralegal at companies similar size to Novartis Pharmaceuticals reported making $95,550, while the average Caucasian Paralegal at similar sized companies reported making $72,293.

How Paralegals at Novartis Pharmaceuticals Rate Their Compensation

The majority of Paralegals at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Paralegals at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals

×
Rate your company